title: A review of the Buehler guinea pig skin sensitization test and its use in a risk assessment process for human skin sensitization.
abstract: The Buehler test is a valuable procedure for screening the sensitization potential of chemicals prior to human exposure. Our experience of over 20 years has shown it to be effective in detecting strong, moderate, and most weak sensitizers. The topical exposure inherent in the Buehler test allows it to be utilized to investigate dose responses, cross reactivity between structurally related chemicals, and the sensitization potential of contaminants in raw material mixtures. For safety assessment purposes, Buehler test results provide an initial indication of the sensitization potential of the material in question under relevant, but exaggerated, exposure conditions. These results can be compared to results on benchmark chemicals to assess sensitization risk for subsequent human exposure. Optimizing the sensitivity of the Buehler test requires adherence to the published methodology and proper interpretation of the challenge and rechallenge data obtained. Adjuvant-type test methods are generally considered to be more sensitive than topical methods. However, when done properly, topical test procedures such as the Buehler test or the open epicutaneous test can accurately detect most chemicals with any realistic potential for sensitizing humans by the topical route. Moreover, from a risk assessment perspective, these topical tests avoid the problems of overestimating the weak sensitization potential of many topically applied materials or underestimating the sensitization potential of very strong sensitizers; both are potential concerns with invasive adjuvant-type test methods. The Buehler test or other topical test methods are particularly valuable for comparative sensitization risk assessment since human sensitization data on benchmark materials are all derived from topical exposure. The risk assessment is developed by comparing the guinea pig data on the new material versus relevant benchmark chemicals or formulations and also by evaluating the existing human sensitization data on the benchmark material. These data are then utilized to predict human sensitization risk from topical exposure to the new material. Confirmation of human safety can be derived from human repeat insult patch testing (HRIPT) and other clinical tests such as the product use test and the diagnostic patch test. Utilized in this manner, the Buehler test is an integral component of an overall skin sensitization safety assessment program for a new chemical or product formulation.
authors.affiliation: Proctor & Gamble Company, Miami Valley Laboratories, Cincinnati, OH 45239-8707.
authors.forename: M K
authors.initials: MK
authors.lastname: Robinson
authors.forename: T L
authors.initials: TL
authors.lastname: Nusair
authors.forename: E R
authors.initials: ER
authors.lastname: Fletcher
authors.forename: H L
authors.initials: HL
authors.lastname: Ritz
mesh_terms: D000818:Animals; D003877:Dermatitis, Contact / Q000209:etiology*; D006168:Guinea Pigs; D006801:Humans; D011237:Predictive Value of Tests; D012882:Skin Tests / Q000379:methods*; D013045:Species Specificity; D014116:Toxicology / Q000379:methods*